5,11-Methenyl-tetrahydrohomofolate (5,11-methenyl-H4homofolate), a reduced folate analogue, inhibited hamster kidney HKSV28 cells grown in vitro. Hypoxanthine protected the cells from growth inhibition but thymidine had no effect, suggesting that the blockage was in the purine biosynthetic pathway. The measurement of formylglycinamide ribonucleotide levels in the presence of the drug showed that a decrease in these levels was a significant and primary effect of the compound, but the effect had an onset time of approximately 4 hr. In contrast, incubation of the cells with the hydrolysis products 11-formyl-H4/H2homofolate resulted in an immediate decrease in formylglycinamide synthesis. The latter formyl derivatives were shown to be potent competitive inhibitors of glycinamide ribonucleotide transformylase (EC 188.8.131.52) from chicken liver. However, the cell inhibition by 5,11-methenyl-H4homofolate was not confined to glycinamide ribonucleotide transformylase, since the cells were not protected by the presence of aminoimidazole carboxamide. Although aminoimidazole carboxamide ribonucleotide transformylase (EC 184.108.40.206) from chicken liver was not inhibited by these derivatives, we propose that intracellular glutamate elongation of the 11-formyl-H4/H2homofolates might lead to inhibition of both transformylase enzymes.
|Original language||English (US)|
|Number of pages||9|
|State||Published - 1984|
All Science Journal Classification (ASJC) codes
- Molecular Medicine